The studies presented here focus on endogenous mechanisms for dispersing platelet thrombi, the formation of which contributes to the pathogenesis of occlusive vascular disorders. These studies represent outgrowths of our initial observation that tissue plasminogen activator initiates the kinetically selective proteolysis of fibrinogen bound to the platelet surface and, in so doing facilitates disaggregation. We plan to test the hypothesis that activation of plasminogen associated with fibrinogen bound to the platelet surface modulates the aggregation response and enhances the effects of other known inhibitors of platelet function, such as prostacyclin and endothelial-derived relaxing factor. We will analyze 1) the structural and functional properties of fibrin and surface-bound fibrinogen important for plasminogen activation, 2) the role of other adhesive macromolecules associated with the platelet aggregate in plasminogen activation and disaggregation, 3) structural determinants of tissue plasminogen activator important for binding to macromolecules in the platelet aggregate, and 4) interactions among endothelial inhibitors of platelet function in promoting disaggregation. These studies should expand our knowledge of the mechanism(s) by which tissue plasminogen activator work(s) within the platelet thrombus, and should provide new insights into mechanisms by which vessel wall (endothelial) products facilitate dissolution of the platelet thrombi that are implicated in the pathogenesis of many common vascular disorders and in reocclusion following interventional vascular therapies.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Modified Research Career Development Award (K04)
Project #
5K04HL002273-03
Application #
3074409
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1989-07-01
Project End
1995-01-31
Budget Start
1992-02-01
Budget End
1993-01-31
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Freedman, J E; Farhat, J H; Loscalzo, J et al. (1996) alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 94:2434-40
Loscalzo, J (1995) Endothelial injury, vasoconstriction, and its prevention. Tex Heart Inst J 22:180-4
Welch, G; Loscalzo, J (1994) Nitric oxide and the cardiovascular system. J Card Surg 9:361-71
Keaney Jr, J F; Gaziano, J M; Xu, A et al. (1994) Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest 93:844-51
Keaney Jr, J F; Shwaery, G T; Xu, A et al. (1994) 17 beta-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation 89:2251-9
Cannon, C P; Maraganore, J M; Loscalzo, J et al. (1993) Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery disease. Am J Cardiol 71:778-82
Rabbani, L E; Loscalzo, J (1993) Atherothrombotic insights into secondary prevention after acute myocardial infarction. Can J Cardiol 9:739-47
Keaney Jr, J F; Gaziano, J M; Xu, A et al. (1993) Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci U S A 90:11880-4
Kestin, A S; Valeri, C R; Khuri, S F et al. (1993) The platelet function defect of cardiopulmonary bypass. Blood 82:107-17
Ouimet, H; Loscalzo, J (1993) Reciprocating autocatalytic interactions between platelets and the activation system. Thromb Res 70:355-64

Showing the most recent 10 out of 23 publications